Literature DB >> 2539705

Molecular cloning and sequencing of the MTV-1 LTR: evidence for a LTR sequence alteration.

C A Crouse1, R J Pauley.   

Abstract

The vertically transmitted Mtv-1 provirus is the primary causative factor of mammary neoplasia in certain C3Hf strains that lack the horizontally transmitted mouse mammary tumor virus (MMTV). The studies here report the molecular cloning of the germ line 4.5 kb Mtv-1 3' EcoRI fragment and sequencing of the 3' Mtv-1 LTR. The Mtv-1 LTR sequence is closely related to the 5' Mtv-11 LTR sequence also reported here, as well as to known Mtv-8 and MMTV LTR sequences in the portion of MMTV and Mtv-8 LTRs previously demonstrated to contain transcriptional regulatory sequences. A 91 bp unique sequence region, Mtv-1 bp 862 to 952, exists in the Mtv-1 LTR, which is upstream of the sequence homology with the MMTV transcriptional regulatory domain. The Mtv-1 unique sequence region is distinct from a 117 bp sequence, bp 862 to 978, in the Mtv-11 LTR sequence as well as reported Mtv-8 and MMTV LTR sequences, and is present in the germ line Mtv-1 5' and 3' LTR-containing restriction fragments. S1 nuclease mapping experiments of C3Hf/Se mammary tumor poly(A) RNA with the cloned Mtv-1 and Mtv-11 LTRs exhibited a specific set of S1 protected fragments demonstrating that Mtv transcripts which accumulate in C3Hf spontaneous mammary tumors are encoded by the Mtv-1 provirus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2539705     DOI: 10.1016/0168-1702(89)90059-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  16 in total

1.  The mouse mammary tumor virus transcription enhancers for hematopoietic progenitor and mammary gland cells share functional elements.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Complete Nucleotide Sequence of Mouse Mammary Tumor Virus from JYG Chinese Wild Mice: Absence of Bacterial Insertion Sequences in the Cloned Viral gag Gene.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

3.  Effect of concurrent graft-versus-host reaction on tissue distribution and infectious titer of murine cytomegalovirus.

Authors:  C Cray; C Crouse; S S Atherton; R B Levy
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Altered mouse mammary tumor virus transcript synthesis in T-cell lymphoma cells.

Authors:  J Racevskis
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors.

Authors:  A Marchetti; J Robbins; G Campbell; F Buttitta; F Squartini; M Bistocchi; R Callahan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes.

Authors:  R J Pauley; P A Gimotty; T J Paine; P J Dawson; S R Wolman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.

Authors:  T V Golovkina; A B Jaffe; S R Ross
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene.

Authors:  F U Reuss; J M Coffin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Detection and characterization of a glycoprotein encoded by the mouse mammary tumor virus long terminal repeat gene.

Authors:  C Brandt-Carlson; J S Butel
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

10.  V beta 17 T-cell deletion by endogenous mammary tumor virus in wild-type-derived mouse strain.

Authors:  E Jouvin-Marche; P A Cazenave; D Voegtle; P N Marche
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.